Bixiye
P25-17 Addition of New Drugs to the Hepatitis C Second Generation Antivirals Prior Authorization (PA) with Quantity Limit (QL) Program
Taariikhda uu dhaqangalayo Barnaamijka: May 25, 2017
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 3121 - 3130 ee natiijooyinka 3273
Bixiye
P28-17 New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Hereditary Angioedema
Taariikhda uu dhaqangalayo Barnaamijka: May 25, 2017
Bixiye
P26-17 New Drug-Related Prior Authorization (PA) Criteria: Urea Cycle Disorders
Taariikhda uu dhaqangalayo Barnaamijka: May 25, 2017
Bixiye
P27-17 New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Antifungal Agents
Taariikhda uu dhaqangalayo Barnaamijka: May 25, 2017
Bixiye
QP11-17 Provider Services Extended Hours and Callback Technology
Taariikhda uu dhaqangalayo Barnaamijka: May 23, 2017
Bixiye
P24-17 AOR No Longer Required for Submission of Organization Determinations for Platinum Blue Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: May 18, 2017
Bixiye
P23-17 Change to Administration of Interpreter Services for MHCP Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: May 16, 2017
Bixiye
QP10-17 Implementation of New Utilization Management Platform
Taariikhda uu dhaqangalayo Barnaamijka: May 15, 2017
Bixiye
P22-17 Identified Claims Processing Issues Grid
Taariikhda uu dhaqangalayo Barnaamijka: May 10, 2017
Bixiye
QP9-17 Change to Certification of Need Form for Special Transportation Services
Taariikhda uu dhaqangalayo Barnaamijka: May 09, 2017